A talented young researcher has joined our team to help tackle the growing epidemics of obesity, insulin resistance and the metabolic syndrome. Shingo Kajimura, PhD, is an accomplished researcher in the regulation of fat cell development and the molecular networks involved in the development of obesity-linked diseases such as type 2 diabetes.
Dr. Kajimura received his BS, MS, and PhD, at the University of Tokyo, and he participated in training programs at the University of Hawaii and the University of Michigan. After completing his PhD in 2006, he conducted his post-doctoral training at the Dana-Farber Cancer Institute and the Harvard Medical School.
Because adipose tissue, fat, serves as a central regulator of the body’s energy metabolism balance, obesity tends to be a major risk factor for metabolic disorders such as type 2 diabetes and cardiovascular disease. Dr. Kajimura’s lab is focused on uncovering the molecular circuits that control fat cell development and function, specifically focusing on brown adipose tissue (BAT), which specializes in dispersing chemical energy in the form of heat. Since recent studies have shown the existence of significant deposits of active BAT in adult humans, Dr. Kajimura hopes to alter the amount and activity of BAT to provide novel therapeutic interventions to counteract obesity and its related disorders.